Data / Form D filings / Treeline Biosciences, Inc.
Treeline Biosciences, Inc.: Form D filings
Treeline Biosciences, Inc., a biotechnology company in Watertown, MA, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on September 4, 2025, reports $200.1 million sold of a $250 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 500 ARSENAL ST., Watertown, MA, 02472
- Phone
- (857) 228-0050
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1856619
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | New notice | $249,999,967 | $200,099,964 | $49,900,003 | 22 | Aug 21, 2025 | sec.gov |
| Oct 17, 2024 | New notice | $421,779,808 | $421,779,808 | 43 | Oct 2, 2024 | sec.gov | |
| Oct 11, 2022 | New notice | $269,340,000 | $261,266,523 | $8,073,477 | 44 | Sep 26, 2022 | sec.gov |
| Apr 30, 2021 | New notice | $220,002,897 | $211,669,568 | $8,333,329 | 34 | Apr 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven H. Elms | Director | |
| Kristina H. Burow | Director | |
| David H. Bonita | Director | |
| Joshua H. Bilenker | Executive Officer, Director, Promoter | |
| Jeffrey H. Engelman | Executive Officer, Director, Promoter | |
| Aftab H. Kherani | Director | |
| Ali H. Satvat | Director | |
| Avi H. Naider | Director | |
| David H. Schenkein | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 1, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Treeline Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.